To view this email as a web page, click here.

Midday Movers: Intel's Israel Deal, Bristol-Myers Squibb Buys RayzeBio

U.S. equities continued their pre-Christmas rally in the last week of 2023, with the Dow, S&P 500, and Nasdaq all up.
Intel received a $3.2 billion incentive deal from the Israeli government, and shares of the chipmaker rose.
Bristol-Myers Squibb will pay $4.1 billion to buy RayzeBio as the drug maker moves to expand its cancer portfolio.

Midday Movers: Intel's Israel Deal, Bristol-Myers Squibb Buys RayzeBio

Israeli Government Gives Intel $3.2 Billion in Incentives to Build a Chip Plant

The Israeli government has given Intel $3.2 billion in incentives to expand its chip manufacturing in the country.

Case-Shiller Home Index Shows Prices Jumped at Highest Rate of 2023

S&P CoreLogic Case-Shiller home price index accelerated at its fastest pace of the year in October, moving higher by 4.8% year-over-year.

5 Things Investors Should Think About for 2024, According to Financial Advisors

As investors examine ways in which they can improve their portfolio in the new year, financial advisors outline what they recommend.

Houses Will Get A Bit More Affordable In 2024, Forecasters Say

If you’re one of the many people who can’t afford to buy a house these days, forecasters have some welcome news: It’s probably going to get better in 2024, although only by a bit.

How can we improve Investopedia Daily? Tell us at daily@investopedia.com

Were you sent this by a friend? Click here to subscribe.

Instagram

TikTok

Youtube

You are receiving this newsletter because you subscribed to the Investopedia Daily newsletter. If you wish to unsubscribe, please click here.

Dotdash Meredith 225 Liberty St, 4th Floor, New York, NY 10281
©2023 All Rights Reserved. Privacy Policy | Terms of Service

Dotdash Meredith

Investopedia is part of the Dotdash Meredith publishing family.